Clinical outcomes of adverse cardiovascular events in patients with acute dapsone poisoning

다국어 초록 (Multilingual Abstract)

Objective Adverse cardiovascular events (ACVEs) account for a large proportion of the morbidities and mortalities associated with drug overdose emergencies. However, there are no published reports regarding outcomes of ACVEs associated with acute dapsone poisoning. Here, the authors retrospectively analyzed ACVEs reported within 48 hours of treatment in patients with acute dapsone poisoning and assessed the significance of ACVEs as early predictors of mortality.
Methods Sixty-one consecutive cases of acute dapsone poisoning that were diagnosed and treated at a regional emergency center between 2006 and 2014 were included in the study. An ACVE was defined as myocardial injury, shock, ventricular dysrhythmia, cardiac arrest, or any combination of these occurring within the first 48 hours of treatment for acute dapsone poisoning.
Results Nineteen patients (31.1%) had evidence of myocardial injury (elevation of serum troponin-I level or electrocardiography signs of ischemia) after dapsone overdose, and there were a total of 19 ACVEs (31.1%), including one case of shock (1.6%). Fourteen patients (23.0%) died from pneumonia or multiple organ failure, and the incidence of ACVEs was significantly higher among non-survivors than among survivors (64.3% vs. 21.3%, P=0.006). ACVE was a significant predictor of mortality (odds ratio, 5.690; 95% confidence interval, 1.428 to 22.675; P=0.014).
Conclusion The incidence of ACVE was significantly higher among patients who died after acute dapsone poisoning. ACVE is a significant predictor of mortality after dapsone overdose, and evidence of ACVE should be carefully sought in these patients.

참고문헌 (Reference)

1 Boehnert MT, "Value of the QRS duration versus the serum druglevel in predicting seizures and ventricular arrhythmias after an acute overdose of tricyclic antidepressants" 313 : 474-479, 1985

2 Agewall S, "Troponin elevation in coronary vs. non-coronary disease" 32 : 404-411, 2011

3 Albertson TE, "TOX-ACLS: toxicologic-oriented advanced cardiac life support" 37 (37): S78-S90, 2001

4 Patel AM, "Role of implantable cardioverter-defibrillators in patients with methadone-induced long QT syndrome" 101 : 209-211, 2008

5 Teo RY, "Presumed dapsone-induced drug hypersensitivity syndrome causing reversible hypersensitivity myocarditis and thyrotoxicosis" 35 : 833-836, 2006

6 Vanden Hoek TL, "Part 12: cardiac arrest in special situations: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care" 122 (122): S829-S861, 2010

7 Li, WH, "Myocarditis in dapsone-induced drug reaction with eosinophilia and systemic symptoms: a case report and review of the literature" 29 : 63-66, 2011

8 Fishbein MC, "Myocardial tissue troponins T and I. An immunohistochemical study in experimental models of myocardial ischemia" 12 : 65-71, 2003

9 Thygesen K, "Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction" 50 : 2173-2195, 2007

10 Manini AF, "Incidence of adverse cardiovascular events in adults following drug overdose" 19 : 843-849, 2012

11 Flomenbaum NE, "Goldfrank’s toxicologic emergencies" McGraw-Hill 2006

12 Schoffstall JM, "Effects of calcium channel blocker overdose-induced toxicity in the conscious dog" 20 : 1104-1108, 1991

13 Coleman MD, "Dapsone-mediated agranulocytosis: risks, possible mechanisms and prevention" 162 : 53-60, 2001

14 Park KH, "Dapsone intoxication: clinical course and characteristics." 48 : 516-521, 2010

15 Zhu YI, "Dapsone and sulfones in dermatology: overview and update" 45 : 420-434, 2001

16 Zhu KJ, "Complete atrioventricular block associated with dapsone therapy: a rare complication of dapsone-induced hypersensitivity syndrome" 34 : 489-492, 2009

17 Zuidema J, "Clinical pharmacokinetics of dapsone" 11 : 299-315, 1986

18 Mingels AM, "Cardiac troponin T elevations, using highly sensitive assay, in recreational running depend on running distance" 99 : 385-391, 2010

19 Lau G, "A fatal case of drug-induced multi-organ damage in a patient with Hansen’s disease: dapsone syndrome or rifampicin toxicity?" 73 : 109-115, 1995

20 Bronstein AC, "2009 Annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 27th annual report" 48 : 979-1178, 2010